ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
No Weighted Avg Shares (Diluted) data reported for this period type.
Weighted Avg Shares (Diluted) vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 178.01M | +19.3% | +28.8% | |
| LTM Mar 2026 | 153.89M | +26.0% | +15.2% | |
| LTM Mar 2026 | 105.94M | +21.0% | +13.7% | |
| LTM Mar 2026 | 80.99M | +13.7% | +21.2% | |
| LTM Mar 2026 | 59.6M | +4.3% | +15.0% | |
| LTM Mar 2026 | 43.27M | +112.6% | +166.1% | |
| LTM Mar 2026 | 31.49M | — | +63.9% | |
| LTM Mar 2026 | 27.53M | +1.8% | +0.4% | |
| FY2025 | 17.11M | — | — | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| Peer median (excluding ADRX) | 59.6M | +19.3% | +18.2% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.